We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (Sirolimus)

This study has been terminated.
(On May 30, 2014, study injections were discontinued at the request of the DSMC. No further recruitment will occur.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01675947
First Posted: August 30, 2012
Last Update Posted: December 10, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
The EMMES Corporation
Santen Inc.
Information provided by (Responsible Party):
National Eye Institute (NEI)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2016
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)